Clinical Trials in Miami

Showing 3781-3800 of 11,431 trials

A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

NCT06390410

Evaluate simufilam levels in the blood of hepatically impaired individuals compared to Healthy individuals of similar demographics

Hepatic Insufficiency

Cassava Sciences, Inc.27 participantsStarted Jun 2024

Lake Forest, California, United States • Miami, Florida, United States • Orlando, Florida, United States

TERMINATEDNA< 1 mile

Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.

NCT04376502

This is an open label single arm phase 2 clinical trial in patients with metastatic solid malignancy of any histology who have previously experienced limited progression in at least 1 and up to 5 lesions while on immune checkpoint inhibitors monotherapy.

Metastatic Carcinoma

Baptist Health South Florida12 participantsStarted Apr 2020

Miami, Florida, United States

COMPLETEDPhase 3< 1 mile

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

NCT04625725

This study will assess the safety and efficacy of a single dose of AZD7442(× 2 IM injections) compared to placebo for the prevention of COVID-19.

COVID-19

AstraZeneca5,197 participantsStarted Nov 2020

Birmingham, Alabama, United States • Tempe, Arizona, United States • Little Rock, Arkansas, United States +86 more locations

A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

Find Trials by Condition in Miami

A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy

Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers

Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations

VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)

ANC-501 in the Treatment of Adults With Major Depressive Disorder

A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)

Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).

Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors

Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials

Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis

Predictive Factors for Medullary Thyroid Cancer Aggressiveness

A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma